National Association of Testing Authorities, Australia
Scope of Accreditation
Northern Tasmanian Pathology Service Launceston General Hospital
Site
Department of Pathology
Accreditation No.
2972
Site No.
2965
Date of Accreditation
17 Aug 1990
Address
274-280 Charles Street
Launceston, TAS 7250
Australia
Contact
Mr Jayachandran Nair
P: +61 (03) 67776684
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Department of Pathology
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
09 Oct 2025
Last Activity Date
07 Jul 2021
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Sputum; Urine | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Rapid onsite evaluation (ROSE); Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin fixed tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigation | Formalin-fixed paraffin-embedded (FFPE) tissues; Fresh tissue; Frozen tissue | Detection of antigenic targets - Various |
| Chemical pathology - Analysis of calculus | Renal calculi | Ammonium; Calcium; Carbonate; Cystine; Magnesium; Oxalate; Phosphate; Uric acid |
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Urine | Amphetamine type substances; Benzodiazepines; Buprenorphine; Cannabinoids; Methadone; Opiates |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Serum | Carbamazepine; Ethanol; Gentamicin (cidomycin, septopal, genticyn, garamycin); Lithium; Methotrexate; Paracetamol (acetaminophen); Phenytoin (dilantin); Salicylate; Tobramycin; Valproate (valproic acid, epilim); Vancomycin |
| Digoxin | ||
| Chemical pathology - Detection and/or quantitation of tumour markers | Serum | Human chorionic gonadotropin (hCG) |
| CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA); Human chorionic gonadotropin (hCG); Prostate specific antigen (PSA); α-Fetoprotein (AFP) | ||
| Chemical pathology - Detection of faecal occult blood | Faeces | Blood |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Serum | Cortisol; Follicle stimulating hormone (FSH); Luteinising hormone (LH); Oestradiol; Progesterone; Prolactin |
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Chemical pathology - Dynamic tests | Sweat | Sweat chloride |
| Chemical pathology - Further investigation of cardiac function | Serum | N-Terminal-pro b-type natriuretic peptide (NT-proBNP); Troponin |
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Serum | HDL - Quantitation |
| Chemical pathology - Further investigation of renal and/or hepatic function | Serum | Uric acid |
| Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Serum | Haptoglobins |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Cerebrospinal fluid (CSF) | Glucose; Lactate; Protein - Total |
| Plasma | Ammonia; Glucose; Lactate | |
| Serum | C-reactive protein (CRP) | |
| Alanine aminotransferase; Albumin; Alkaline phosphatase; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; Calcium - Total; Chloride; Cholesterol - LDL; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urea; γ-Glutamyltransferase | ||
| Serum; Urine | Osmolality | |
| Urine | Albumin; Calcium - Total; Chloride; Creatinine; Potassium; Protein - Total; Sodium; Urate; Urea | |
| Chemical pathology - Investigation for folate deficiency | Serum | Folate |
| Chemical pathology - Investigation of malabsorption | Faeces | Reducing substances |
| Chemical pathology - Investigation of maternal markers to detect foetal abnormality | Serum | Human chorionic gonadotropin (hCG) - Total |
| Chemical pathology - Iron studies | Serum | Ferritin; Iron; Transferrin |
| Chemical pathology - Quantitation of vitamins | Serum | 25-Hydroxyvitamin D; Cobalamin (vitamin B12) |
| Chemical pathology - Tests for thyroid function | Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
| Haematology - Examination of blood films by special staining | Blood | Malaria |
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Detection and quantitation of foetal red cell antigens |
| Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell index or indices; Reticulocytes |
| Differential number; Morphology | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Plasma | Viscoelastic haemostatic testing (VHT) |
| Heparin induced thrombotic thrombocytopenia (HITT) | ||
| Activated partial thromboplastin time (APTT); D-dimer; Factor VIII; Factor X; Fibrinogen; International normalised ratio (INR) | ||
| Haematology - Investigation of haemoglobinopathy (excluding thalassemia) | Blood | Haemoglobin S (HbS) - Presence |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunohaematology - Blood group antibody detection | Blood | Duffy system; Kell system; M and N factors; Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Red blood cell phenotyping |
| Other blood group antibodies; Rh | ||
| Antibody titration | ||
| Antibody elution | ||
| Immunohaematology - Investigation of blood transfusion reactions | Blood products | Antibodies |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Serum | Rheumatoid factor |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Cerebrospinal fluid (CSF) | Oligoclonal bands |
| Plasma; Serum | Cryofibrinogen; Cryoglobulins | |
| Serum; Urine | Detection and amount of paraproteins; Protein classes | |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Serum | Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
| Microbiology - Bacteriology - Detection and identification of crystalline material | Synovial fluid | Crystal detection and identification |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Blood; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Faeces; Fluids; Genital swabs; Post-operative wounds; Skin; Sputum; Throat swabs; Tissues; Urine; Wound swabs | Antibiotic susceptibility; Bacteria; Pathogenic microorganisms |
| Antibiotic susceptibility; Bacteria; Pathogenic microorganisms | ||
| Bacteria; Pathogenic microorganisms | ||
| Bacteria; Pathogenic identification; Pathogenic microorganisms | ||
| Pathogenic identification; Pathogenic identification and antibiotic susceptibility | ||
| Aspirates; Blood; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Fluids; Genital swabs; Post-operative wounds; Skin; Sputum; Throat swabs; Tissues; Urine; Wound swabs | Bacteria; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Blood | Bacteria; Pathogenic microorganisms | |
| Faeces | Clostridioides difficile toxin | |
| Urine | Streptococcus pneumoniae antigen | |
| Legionella antigen | ||
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Amniotic fluid; Aspirates; Bacterial isolates; Blood; Bronchial swabs; Bronchial washings; Bronchoalveolar lavage; Cerebrospinal fluid (CSF); Cervical specimen; Cervical swabs; Dry swabs; Eye swabs; Faeces; Fluids; Genital swabs; Liquid based cytology specimens; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Paraffin embedded tissue; Pericardial fluid; Plasma; Pleural fluid; Rectal swabs; Respiratory specimens; Self-collected vaginal swabs; Semen; Serum; Sputum; Sterile site; Tampons; Throat swabs; Tissues; Tonsil swabs; Urethral swabs; Urine; Vaginal swabs; Vomitus; Wound swabs | Clostridioides difficile toxin; Staphylococcus aureus; Carbapenem resistant Enterobacteriaceae (CRE); Methicillin resistant Staphylococcus aureus (MRSA); Vancomycin resistant Enterococci (VRE) |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Blood | Malaria |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Aspirates; Blood; Blood culture; Nasal aspirates/washes; Nasal swabs; Plasma; Saliva; Serum | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) A/B; Respiratory syncytial virus (RSV) |
| Nasal aspirates/washes; Nasopharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Respiratory specimens | Mycobacteria identification |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Cerebrospinal fluid (CSF); Hair; Nails; Skin scrapings | Fungi identification; Yeasts identification |
| Cerebrospinal fluid (CSF); Serum | Cryptococcus antigen | |
| Hair; Nails; Skin scrapings | Fungi identification; Yeasts identification | |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Faeces | Cysts; Ova; Parasites | |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood | Infectious mononucleosis |
| Serum | Cytomegalovirus (CMV); Epstein-Barr virus; Toxoplasma; Varicella zoster virus (VZV) | |
| Mycoplasma pneumoniae | ||
| Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Human immunodeficiency virus (HIV); Rubella IgG antibody; Syphilis Treponema pallidum antibody | ||
| Hepatitis A virus (HAV); Hepatitis C virus (HCV) | ||
| Microbiology - Virology - Detection of pathogenic viruses | Faeces | Norovirus |
Diabetic Centre
ISO 15189 (2012)
Human Pathology
Medicare expiry date
09 Oct 2025
Last Activity Date
07 Jul 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Urine | Microalbumin |
Emergency Department
ISO 15189 (2012)
Human Pathology
Medicare expiry date
09 Oct 2025
Last Activity Date
07 Jul 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Intensive Care Unit
ISO 15189 (2012)
Human Pathology
Medicare expiry date
09 Oct 2025
Last Activity Date
07 Jul 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Neonate Intensive Care Unit
ISO 15189 (2012)
Human Pathology
Medicare expiry date
09 Oct 2025
Last Activity Date
07 Jul 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2972
Site No.
2965
Print date
26 Apr 2024
END OF SCOPE
